The Institution Biosafety Committee (IBC) is responsible for the review of University research and teaching activities involving recombinant and synthetic nucleic acid molecules, infectious agents, biologically-derived toxins, or other potentially hazardous biological agents as described in the University of Minnesota Board of Regents Policy and the University-wide Administrative Policy,
The IBC’s policies are periodically evaluated and revised as influenced by regulatory agencies and administrative changes.
All approved policy revisions will be posted on this site as they are implemented, along with the revision date for reference. The most current version of all Institutional Biosafety Committee policies are listed here.
General Administration
Organization & Roles of IBC
Functions & Operations
| Number | Title |
|---|---|
| 301 | Application Requirements |
| 302 | Administrative Pre-Review |
| 303 | Meeting Preparation |
| 304 | Convening an IBC Meeting |
| 305 | Minutes of Meetings |
| 306 | Records Management |
| 307 | IBC Communication |
| 308 | Access to Meetings |
| 309 | IBC Interactions with IRB |
| 310 | IBC Interactions with IACUC |
| 311 | Interactions with Other UMN Units |
| 312 | Review of BSL3 Research |
| 313 |
Review of Research/Activities
Investigator Responsibilities
| Number | Title |
|---|---|
| 700 | Principal Investigator Responsibilities |
| 701 | Required Training |
| 702 | PI Signature Requirements |
| 703 | Disagreement with IBC Decisions |
| 704 | Certification of Biological Safety Cabinets |